Prevalencia de la psoriasis en España en la era de los agentes biológicos-Reference-Cited by-同舟云学术

Prevalencia de la psoriasis en España en la era de los agentes biológicos

Published:2014-06 Issue:5 Volume:105 Page:504-509
ISSN:0001-7310
Container-title:Actas Dermo-Sifiliográficas
language:es
Short-container-title:Actas Dermo-Sifiliográficas

Author:

Ferrándiz C.,Carrascosa J.M.,Toro M.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference19 articles.

1. Epidemiologic strategies in psoriasis research;Nall;Int J Dermatol,1994

2. Prevalence of psoriasis in Spain (Epiderma Project: Phase I);Ferrandiz;J Eur Acad Dermatol Venereol,2001

3. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento;Puig;Actas Dermosifiliogr,2013

4. Van der Kerkhof PC, Schalkwijk J. Psoriasis. En: Bolognia JL, Jorizzo JL, Rapini RP, editores. Dermatology. 2nd ed. London: Mosby Elsevier; 2008. p. 115–36.

5. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data;Simpson;Clin Exp Allergy,2002

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities;Journal of Clinical Medicine;2024-01-16

2. [Translated article] Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study;Actas Dermo-Sifiliográficas;2024-01

3. Percepción de la mujer con psoriasis en la planificación familiar: Estudio descriptivo, transversal y multicéntrico;Actas Dermo-Sifiliográficas;2024-01

4. The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain;Frontiers in Public Health;2023-01-26

5. Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic Guidelines;Life;2022-11-14